Thomas Schreiner
Position:
Phone:
Email:
 

Publications 2017

Groch S, Schreiner T, Rasch B, Huber R, Wilhelm I (2017)
Prior knowledge is essential for the beneficial effect of targeted memory reactivation during sleep
Sci Rep, 7, 39763
PubMed 28051138

Publications 2016

Göldi M, Schreiner T (2016)
Clicking the brain into deep sleep. Commentary on Weigenand et al. ()
Eur J Neurosci (in press)
PubMed 27973741

Lehmann M, Schreiner T, Seifritz E, Rasch B (2016)
Emotional arousal modulates oscillatory correlates of targeted memory reactivation during NREM, but not REM sleep
Sci Rep, 6, 39229
PubMed 27982120

Schreiner T, Rasch B (2016)
The beneficial role of memory reactivation for language learning during sleep: A review
Brain Lang (in press)
PubMed 27036946

Schreiner T, Rasch B (2016)
To gain or not to gain - The complex role of sleep for memory: Comment on Dumay (2016)
Cortex (in press)
PubMed 27423210

Publications 2015

Seland M, Bjøro T, Furre T, Schreiner T, Bollerslev J, Fosså SD, Loge JH, Holte H, Kiserud CE (2015)
Hormonal dysfunction is frequent in cancer survivors treated with radiotherapy to the head and neck region
J Cancer Surviv, 9 (4), 630-40
PubMed 25750158

Seland M, Holte H, Bjøro T, Schreiner T, Bollerslev J, Loge JH, Fosså SD, Kiserud CE (2015)
Chronic fatigue is prevalent and associated with hormonal dysfunction in long-term non-Hodgkin lymphoma survivors treated with radiotherapy to the head and neck region
Leuk Lymphoma, 56 (12), 3306-14
PubMed 25827172

Publications 2014

Wierckx K, Van Caenegem E, Schreiner T, Haraldsen I, Fisher AD, Toye K, Kaufman JM, T'Sjoen G (2014)
Cross-sex hormone therapy in trans persons is safe and effective at short-time follow-up: results from the European network for the investigation of gender incongruence
J Sex Med, 11 (8), 1999-2011
PubMed 24828032

Publications 2013

Jørgensen AP, Ueland T, Sode-Carlsen R, Schreiner T, Rabben KF, Farholt S, Høybye C, Christiansen JS, Bollerslev J (2013)
Glucose homeostasis in adults with Prader-Willi syndrome during treatment with growth hormone: results from a 12-month prospective study
Growth Horm IGF Res, 24 (1), 16-21
PubMed 24360789

Papathomas TG, Gaal J, Corssmit EP, Oudijk L, Korpershoek E, Heimdal K, Bayley JP, Morreau H, van Dooren M, Papaspyrou K, Schreiner T, Hansen T, Andresen PA, Restuccia DF, van Kessel I, van Leenders GJ, Kros JM, Looijenga LH, Hofland LJ, Mann W, van Nederveen FH, Mete O, Asa SL, de Krijger RR, Dinjens WN (2013)
Non-pheochromocytoma (PCC)/paraganglioma (PGL) tumors in patients with succinate dehydrogenase-related PCC-PGL syndromes: a clinicopathological and molecular analysis
Eur J Endocrinol, 170 (1), 1-12
PubMed 24096523

Publications 2011

Carlsen SM, Svartberg J, Schreiner T, Aanderud S, Johannesen O, Skeie S, Lund-Johansen M, Fougner SL, Bollerslev J, POTA study group (2011)
Six-month preoperative octreotide treatment in unselected, de novo patients with acromegaly: effect on biochemistry, tumour volume, and postoperative cure
Clin Endocrinol (Oxf), 74 (6), 736-43
PubMed 21521254

Ramm-Pettersen J, Berg-Johnsen J, Hol PK, Roy S, Bollerslev J, Schreiner T, Helseth E (2011)
Intra-operative MRI facilitates tumour resection during trans-sphenoidal surgery for pituitary adenomas
Acta Neurochir (Wien), 153 (7), 1367-73
PubMed 21523361

Sode-Carlsen R, Farholt S, Rabben KF, Bollerslev J, Schreiner T, Jurik AG, Christiansen JS, Höybye C (2011)
Growth hormone treatment in adults with Prader-Willi syndrome: the Scandinavian study
Endocrine, 41 (2), 191-9
PubMed 22081257

Sode-Carlsen R, Farholt S, Rabben KF, Bollerslev J, Schreiner T, Jurik AG, Frystyk J, Christiansen JS, Höybye C (2011)
Growth hormone treatment for two years is safe and effective in adults with Prader-Willi syndrome
Growth Horm IGF Res, 21 (4), 185-90
PubMed 21664161

Publications 2010

Sode-Carlsen R, Farholt S, Rabben KF, Bollerslev J, Schreiner T, Jurik AG, Christiansen JS, Höybye C (2010)
One year of growth hormone treatment in adults with Prader-Willi syndrome improves body composition: results from a randomized, placebo-controlled study
J Clin Endocrinol Metab, 95 (11), 4943-50
PubMed 20702523

Sode-Carlsen R, Farholt S, Rabben KF, Bollerslev J, Schreiner T, Jurik AG, Christiansen JS, Höybye C (2010)
Body composition, endocrine and metabolic profiles in adults with Prader-Willi syndrome
Growth Horm IGF Res, 20 (3), 179-84
PubMed 20199883

Tønseth KA, Bjark T, Kratz G, Gross A, Kirschner R, Schreiner T, Diseth TH, Haraldsen I (2010)
[Sex reassignment surgery in transsexuals]
Tidsskr Nor Laegeforen, 130 (4), 376-9
PubMed 20220861

Publications 2009

Ueland T, Fougner SL, Godang K, Lekva T, Schurgers LJ, Scholz H, Halvorsen B, Schreiner T, Aukrust P, Bollerslev J (2009)
Associations between body composition, circulating interleukin-1 receptor antagonist, osteocalcin, and insulin metabolism in active acromegaly
J Clin Endocrinol Metab, 95 (1), 361-8
PubMed 19880791

Ueland T, Fougner SL, Godang K, Lekva T, Schurgers LJ, Scholz H, Halvorsen B, Schreiner T, Aukrust PL, Bollerslev J (2009)
Associations between Body Composition, Circulating Interleukin-1 Receptor Antagonist, Osteocalcin, and Insulin Metabolism in Active Acromegaly
Endocr Rev, 30 (7), 927
PubMed 28199500

Publications 2008

Carlsen SM, Lund-Johansen M, Schreiner T, Aanderud S, Johannesen O, Svartberg J, Cooper JG, Hald JK, Fougner SL, Bollerslev J, Preoperative Octreotide Treatment of Acromegaly study group (2008)
Preoperative octreotide treatment in newly diagnosed acromegalic patients with macroadenomas increases cure short-term postoperative rates: a prospective, randomized trial
J Clin Endocrinol Metab, 93 (8), 2984-90
PubMed 18492760

Vik-Mo EO, Øksnes M, Pedersen PH, Wentzel-Larsen T, Rødahl E, Thorsen F, Schreiner T, Aanderud S, Lund-Johansen M (2008)
Gamma knife stereotactic radiosurgery of Nelson syndrome
Eur J Endocrinol, 160 (2), 143-8
PubMed 18996962

Publications 2007

Vik-Mo EO, Oksnes M, Pedersen PH, Wentzel-Larsen T, Rødahl E, Thorsen F, Schreiner T, Aanderud S, Lund-Johansen M (2007)
Gamma knife stereotactic radiosurgery for acromegaly
Eur J Endocrinol, 157 (3), 255-63
PubMed 17766706

Publications 2006

Bollerslev J, Ueland T, Jørgensen AP, Fougner KJ, Wergeland R, Schreiner T, Burman P (2006)
Positive effects of a physiological dose of GH on markers of atherogenesis: a placebo-controlled study in patients with adult-onset GH deficiency
Eur J Endocrinol, 154 (4), 537-43
PubMed 16556716

Evang JA, Carlsen SM, Svartberg J, Aanderud S, Johannesen Ø, Schreiner T, Ramm-Pettersen J, Bakke SJ, Lund-Johansen M, Bollerslev J (2006)
[Endogenous Cushing's syndrome]
Tidsskr Nor Laegeforen, 126 (5), 599-602
PubMed 16505869

Publications 2005

Bollerslev J, Hallén J, Fougner KJ, Jørgensen AP, Kristo C, Fagertun H, Gudmundsen O, Burman P, Schreiner T (2005)
Low-dose GH improves exercise capacity in adults with GH deficiency: effects of a 22-month placebo-controlled, crossover trial
Eur J Endocrinol, 153 (3), 379-87
PubMed 16131600

Schreiner T, Schaefer UF, Loth H (2005)
Immediate drug release from solid oral dosage forms
J Pharm Sci, 94 (1), 120-33
PubMed 15761936

Publications 2003

Lund-Johansen M, Aanderud S, Schreiner T, Bollerslev J, Bakke SJ, Johannesen Ø, Carlsen SM, Cappelen J, Svartberg J (2003)
[Hormonally inactive pituitary adenomas]
Tidsskr Nor Laegeforen, 123 (16), 2253-6
PubMed 14508546

Publications 2002

Bjøro T, Holmen J, Krüger Ø, Midthjell K, Hunstad K, Schreiner T, Sandnes L, Brochmann H (2002)
[Prevalence of hypothyroidism and hyperthyroidism in Nord-Trondelag]
Tidsskr Nor Laegeforen, 122 (10), 1022-8
PubMed 12082694

Schreiner T, Mohrs MR, Blau-Wasser R, von Krempelhuber A, Steinert M, Schleicher M, Noegel AA (2002)
Loss of the F-actin binding and vesicle-associated protein comitin leads to a phagocytosis defect
Eukaryot Cell, 1 (6), 906-14
PubMed 12477791

Svartberg J, Carlsen SM, Cappelen J, Aanderud S, Johansen ML, Schreiner T, Kollevold T, Bakke S, Bollerslev J (2002)
[Hyperprolactinemia and prolactinemia--investigation and treatment]
Tidsskr Nor Laegeforen, 122 (5), 494-8
PubMed 11961978